State Sen. James Maroney, a leading voice for AI regulation, is optimistic about passing a new bill aimed at protecting residents from potentially harmful and discriminatory uses of algorithms. Last year’s proposed legislation faced challenges, but Maroney believes 2025 offers a…
The FDA has shared draft guidance on using AI for regulatory decisions in drug and biologic products.
The FDA has released a draft titled “Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products”. This document outlines key recommendations for using AI in regulatory decisions, ensuring safety, transparency, and accuracy in drug…